Prediction Case File
YouTubeTracking Live

Palantir stock is down significantly since I warned investors not to buy.

1 extracted signal · 0 resolved · 1 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFAIndependent analyst profile
Source published
20 Nov 2025, 23:09 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Palantir stock is down significantly since I warned investors not to buy.
Source overview

AI-generated source summary

The analyst reaffirms his previous November 3, 2025, recommendation against purchasing Palantir stock. While acknowledging the company's strong business performance, including accelerating revenue growth, expanding profit margins, increasing cash flow from operations to sales, and a high return on invested capital, his advice stems from valuation concerns. On November 3, 2025, Palantir traded at approximately $213 per share. By November 19, 2025, the stock had declined to $166.49, despite a year-to-date gain of over 118% and a six-month increase of 31%. The analyst's updated discounted cash flow (DCF) model, which incorporates upgraded free cash flow expectations and a reduced risk profile via a lower beta, yields an intrinsic value per share of $70.52. This intrinsic value is significantly below the current market price of $165.49, indicating the stock is overvalued. Free cash flow is projected to increase robustly from $1.93 billion in 2025 to $33.49 billion by 2034, with a long-term growth rate estimated at 6%. Despite these excellent prospects, the analyst maintains a 'Hold/Market Perform' rating, advising investors to await a lower price, as the company's future growth is already largely priced into its current valuation.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

Parkev Tatevosian, CFA

Platform-wide history, separate from this source evaluation.

Reliability
41.8
Tracked signals
1293
Historical success
25.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail